Amphotericin B Zentiva 50 mg
Amphotericin B Zentiva 50 mg is a medicine authorised by Swissmedic under authorisation number 70177. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 March 2026 and the authorisation is limited until 02 March 2031. ATC code J02AA01 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 70177 |
|---|---|
| Name | Amphotericin B Zentiva 50 mg |
| Full name | Amphotericin B Zentiva 50 mg, Pulver zur Herstellung einer Infusionsdispersion (i.v.) |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AA01 |
| First authorisation | 03 March 2026 |
| Authorisation validity | 02 March 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amphotericin B Zentiva 50 mg, Pulver zur Herstellung einer Infusionsdispersion (i.v.) | A | 03 March 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AA01 | 08.06.0. | A |
| 2 | 10 | Durchstechflasche(n) | J02AA01 | 08.06.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amphotericin B Zentiva 50 mg authorised in Switzerland?
Yes. Amphotericin B Zentiva 50 mg is authorised by Swissmedic under authorisation number 70177, data as of 01 September 2026. The authorisation is limited until 02 March 2031.
Which dispensing category does Amphotericin B Zentiva 50 mg have?
Amphotericin B Zentiva 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Amphotericin B Zentiva 50 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.